| Net income (loss) | -25.74M |
| Depreciation and amortization | |
| Stock-based compensation | 164K |
| Other-than-temporary impairment on investment securities | 147K |
| Net realized gains (losses) on sales and redemptions of investments | |
| Other | 170K |
| Premiums and fees receivable | |
| Loss and loss adjustment expense reserves | |
| Unearned premiums and fees | 6.39M |
| Other | -692K |
| Net cash provided by (used in) operating activities | |
| Purchases of investments, available-for-sale | -62.95M |
| Maturities and paydowns of investments, available-for-sale | 9.16M |
| Sales of investments, available-for-sale | 66.88M |
| Capital expenditures | -1.52M |
| Other | |
| Net cash provided by investing activities | |
| Payments on borrowings | |
| Purchase of treasury stock | |
| Net cash used in financing activities | |
| Net change in cash and cash equivalents | |
| Cash and cash equivalents, beginning of period | |
| Cash and cash equivalents, end of period | |